市場調査レポート
商品コード
1402294

POC血液診断の世界市場 2024-2028

Global POC Haematology Diagnostics Market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 164 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
POC血液診断の世界市場 2024-2028
出版日: 2023年12月26日
発行: TechNavio
ページ情報: 英文 164 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

POC血液診断市場は2023-2028年に71億5,000万米ドル、予測期間中のCAGRは10.33%で成長すると予測されます。

当レポートでは、POC血液診断市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、血液疾患や感染症の有病率の増加、POC血液診断製品の上市の増加、ベンチトップからポータブル血液診断システムへのパラダイムシフトなどによって牽引されています。

市場範囲
基準年 2023
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 9.65%
CAGR 10.33%
増分額 71億5,000万米ドル

本調査では、今後数年間のPOC血液診断市場の成長を牽引する主要因の一つとして、オンラインマーケティングの増加を挙げています。また、OEMの増加や次世代血液診断製品の採用増加も市場の大きな需要につながっています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • 世界のPOC血液学診断市場 2018-2022
  • エンドユーザーセグメント分析 2018-2022
  • 製品セグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 病院と診療所:市場規模と予測 2023-2028
  • ホームケア設定:市場規模と予測 2023-2028
  • 臨床診断研究所:市場規模と予測 2023-2028
  • 市場機会:エンドユーザー別

第7章 市場セグメンテーション:製品別

  • 市場セグメント
  • 比較:製品別
  • 消耗品:市場規模と予測 2023-2028
  • システム:市場規模と予測 2023-2028
  • 市場機会:製品別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • ドイツ:市場規模と予測 2023-2028
  • 英国:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • カナダ:市場規模と予測 2023-2028
  • 市場機会:地域情勢別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Abbott Laboratories
  • Danaher Corp.
  • DIAGON Kft.
  • Diamond Diagnostics Inc.
  • Drucker Diagnostics LLC
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann La Roche Ltd.
  • HORIBA Ltd.
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • Nova Biomedical Corp.
  • Mindray Bio medical Electronics Co. Ltd.
  • Siemens AG
  • Sysmex Corp.
  • Transasia Bio Medicals Ltd.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global poc hematology diagnostics market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Homecare settings - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Homecare settings - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Homecare settings - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Homecare settings - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Data Table on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
  • Exhibits44: Chart on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by End-user ($ billion)
  • Exhibits47: Data Table on Market opportunity by End-user ($ billion)
  • Exhibits48: Chart on Product - Market share 2023-2028 (%)
  • Exhibits49: Data Table on Product - Market share 2023-2028 (%)
  • Exhibits50: Chart on Comparison by Product
  • Exhibits51: Data Table on Comparison by Product
  • Exhibits52: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
  • Exhibits53: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
  • Exhibits54: Chart on Consumables - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Systems - Market size and forecast 2023-2028 ($ billion)
  • Exhibits57: Data Table on Systems - Market size and forecast 2023-2028 ($ billion)
  • Exhibits58: Chart on Systems - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Systems - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Market opportunity by Product ($ billion)
  • Exhibits61: Data Table on Market opportunity by Product ($ billion)
  • Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits65: Chart on Geographic comparison
  • Exhibits66: Data Table on Geographic comparison
  • Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits105: Impact of drivers and challenges in 2023 and 2028
  • Exhibits106: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits107: Overview on factors of disruption
  • Exhibits108: Impact of key risks on business
  • Exhibits109: Vendors covered
  • Exhibits110: Matrix on vendor position and classification
  • Exhibits111: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
  • Exhibits112: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
  • Exhibits113: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
  • Exhibits114: Abbott Laboratories - Overview
  • Exhibits115: Abbott Laboratories - Business segments
  • Exhibits116: Abbott Laboratories - Key news
  • Exhibits117: Abbott Laboratories - Key offerings
  • Exhibits118: Abbott Laboratories - Segment focus
  • Exhibits119: Danaher Corp. - Overview
  • Exhibits120: Danaher Corp. - Business segments
  • Exhibits121: Danaher Corp. - Key news
  • Exhibits122: Danaher Corp. - Key offerings
  • Exhibits123: Danaher Corp. - Segment focus
  • Exhibits124: DIAGON Kft. - Overview
  • Exhibits125: DIAGON Kft. - Product / Service
  • Exhibits126: DIAGON Kft. - Key offerings
  • Exhibits127: Diamond Diagnostics Inc. - Overview
  • Exhibits128: Diamond Diagnostics Inc. - Product / Service
  • Exhibits129: Diamond Diagnostics Inc. - Key offerings
  • Exhibits130: Drucker Diagnostics LLC - Overview
  • Exhibits131: Drucker Diagnostics LLC - Product / Service
  • Exhibits132: Drucker Diagnostics LLC - Key offerings
  • Exhibits133: EKF Diagnostics Holdings Plc - Overview
  • Exhibits134: EKF Diagnostics Holdings Plc - Business segments
  • Exhibits135: EKF Diagnostics Holdings Plc - Key offerings
  • Exhibits136: EKF Diagnostics Holdings Plc - Segment focus
  • Exhibits137: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits139: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits142: HORIBA Ltd. - Overview
  • Exhibits143: HORIBA Ltd. - Business segments
  • Exhibits144: HORIBA Ltd. - Key offerings
  • Exhibits145: HORIBA Ltd. - Segment focus
  • Exhibits146: Medsource Ozone Biomedicals Pvt. Ltd. - Overview
  • Exhibits147: Medsource Ozone Biomedicals Pvt. Ltd. - Product / Service
  • Exhibits148: Medsource Ozone Biomedicals Pvt. Ltd. - Key offerings
  • Exhibits149: Nova Biomedical Corp. - Overview
  • Exhibits150: Nova Biomedical Corp. - Product / Service
  • Exhibits151: Nova Biomedical Corp. - Key offerings
  • Exhibits152: Mindray Bio medical Electronics Co. Ltd. - Overview
  • Exhibits153: Mindray Bio medical Electronics Co. Ltd. - Product / Service
  • Exhibits154: Mindray Bio medical Electronics Co. Ltd. - Key offerings
  • Exhibits155: Siemens AG - Overview
  • Exhibits156: Siemens AG - Business segments
  • Exhibits157: Siemens AG - Key news
  • Exhibits158: Siemens AG - Key offerings
  • Exhibits159: Siemens AG - Segment focus
  • Exhibits160: Sysmex Corp. - Overview
  • Exhibits161: Sysmex Corp. - Business segments
  • Exhibits162: Sysmex Corp. - Key offerings
  • Exhibits163: Sysmex Corp. - Segment focus
  • Exhibits164: Transasia Bio Medicals Ltd. - Overview
  • Exhibits165: Transasia Bio Medicals Ltd. - Product / Service
  • Exhibits166: Transasia Bio Medicals Ltd. - Key offerings
  • Exhibits167: Inclusions checklist
  • Exhibits168: Exclusions checklist
  • Exhibits169: Currency conversion rates for US$
  • Exhibits170: Research methodology
  • Exhibits171: Validation techniques employed for market sizing
  • Exhibits172: Information sources
  • Exhibits173: List of abbreviations
目次
Product Code: IRTNTR45645

Abstract

The POC haematology diagnostics market is forecasted to grow by USD 7.15 bn during 2023-2028, accelerating at a CAGR of 10.33% during the forecast period. The report on the POC haematology diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of blood disorders and infectious diseases, increasing growth in POC hematology diagnostics product launches, and the paradigm shift from benchtop to portable hematology diagnostic systems.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20249.65%
CAGR10.33%
Incremental Value$7.15bn

Technavio's POC haematology diagnostics market is segmented as below:

By End-user

  • Hospitals and clinics
  • Homecare settings
  • Clinical diagnostic laboratories

By Product

  • Consumables
  • Systems

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increase in online marketing as one of the prime reasons driving the POC haematology diagnostics market growth during the next few years. Also, increase in the number of OEMs and increase in adoption of next-generation hematology diagnostic products will lead to sizable demand in the market.

The report on the POC haematology diagnostics market covers the following areas:

  • POC haematology diagnostics market sizing
  • POC haematology diagnostics market forecast
  • POC haematology diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC haematology diagnostics market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Chengdu Seamaty Technology Co. Ltd., Danaher Corp., DIAGON Kft., Diamond Diagnostics Inc., Drucker Diagnostics LLC, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Medsource Ozone Biomedicals Pvt. Ltd., Norma Instruments Zrt., Nova Biomedical Corp., PixCell Medical Technologies Ltd., S.D. Sight Diagnostics Ltd., Sekisui Diagnostics LLC, Mindray Bio medical Electronics Co. Ltd., Siemens AG, Sysmex Corp., and Transasia Bio Medicals Ltd.. Also, the POC haematology diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global POC hematology diagnostics market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global poc hematology diagnostics market 2018 - 2022 ($ billion)
  • 4.2 End-user Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
  • 4.3 Product Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Hospitals and clinics - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 35: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 36: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • 6.4 Homecare settings - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Homecare settings - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 39: Data Table on Homecare settings - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 40: Chart on Homecare settings - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Homecare settings - Year-over-year growth 2023-2028 (%)
  • 6.5 Clinical diagnostic laboratories - Market size and forecast 2023-2028
  • Exhibit 42: Chart on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 43: Data Table on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 44: Chart on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by End-user
  • Exhibit 46: Market opportunity by End-user ($ billion)
  • Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 48: Chart on Product - Market share 2023-2028 (%)
  • Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
  • 7.2 Comparison by Product
  • Exhibit 50: Chart on Comparison by Product
  • Exhibit 51: Data Table on Comparison by Product
  • 7.3 Consumables - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 53: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 54: Chart on Consumables - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
  • 7.4 Systems - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Systems - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 57: Data Table on Systems - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 58: Chart on Systems - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Systems - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Product
  • Exhibit 60: Market opportunity by Product ($ billion)
  • Exhibit 61: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 65: Chart on Geographic comparison
  • Exhibit 66: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Germany - Market size and forecast 2023-2028
  • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
  • Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
  • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 Canada - Market size and forecast 2023-2028
  • Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
  • Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 107: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 108: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 109: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 110: Matrix on vendor position and classification
  • 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl
  • Exhibit 111: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
  • Exhibit 112: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
  • Exhibit 113: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
  • 12.4 Abbott Laboratories
  • Exhibit 114: Abbott Laboratories - Overview
  • Exhibit 115: Abbott Laboratories - Business segments
  • Exhibit 116: Abbott Laboratories - Key news
  • Exhibit 117: Abbott Laboratories - Key offerings
  • Exhibit 118: Abbott Laboratories - Segment focus
  • 12.5 Danaher Corp.
  • Exhibit 119: Danaher Corp. - Overview
  • Exhibit 120: Danaher Corp. - Business segments
  • Exhibit 121: Danaher Corp. - Key news
  • Exhibit 122: Danaher Corp. - Key offerings
  • Exhibit 123: Danaher Corp. - Segment focus
  • 12.6 DIAGON Kft.
  • Exhibit 124: DIAGON Kft. - Overview
  • Exhibit 125: DIAGON Kft. - Product / Service
  • Exhibit 126: DIAGON Kft. - Key offerings
  • 12.7 Diamond Diagnostics Inc.
  • Exhibit 127: Diamond Diagnostics Inc. - Overview
  • Exhibit 128: Diamond Diagnostics Inc. - Product / Service
  • Exhibit 129: Diamond Diagnostics Inc. - Key offerings
  • 12.8 Drucker Diagnostics LLC
  • Exhibit 130: Drucker Diagnostics LLC - Overview
  • Exhibit 131: Drucker Diagnostics LLC - Product / Service
  • Exhibit 132: Drucker Diagnostics LLC - Key offerings
  • 12.9 EKF Diagnostics Holdings Plc
  • Exhibit 133: EKF Diagnostics Holdings Plc - Overview
  • Exhibit 134: EKF Diagnostics Holdings Plc - Business segments
  • Exhibit 135: EKF Diagnostics Holdings Plc - Key offerings
  • Exhibit 136: EKF Diagnostics Holdings Plc - Segment focus
  • 12.10 F. Hoffmann La Roche Ltd.
  • Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.11 HORIBA Ltd.
  • Exhibit 142: HORIBA Ltd. - Overview
  • Exhibit 143: HORIBA Ltd. - Business segments
  • Exhibit 144: HORIBA Ltd. - Key offerings
  • Exhibit 145: HORIBA Ltd. - Segment focus
  • 12.12 Medsource Ozone Biomedicals Pvt. Ltd.
  • Exhibit 146: Medsource Ozone Biomedicals Pvt. Ltd. - Overview
  • Exhibit 147: Medsource Ozone Biomedicals Pvt. Ltd. - Product / Service
  • Exhibit 148: Medsource Ozone Biomedicals Pvt. Ltd. - Key offerings
  • 12.13 Nova Biomedical Corp.
  • Exhibit 149: Nova Biomedical Corp. - Overview
  • Exhibit 150: Nova Biomedical Corp. - Product / Service
  • Exhibit 151: Nova Biomedical Corp. - Key offerings
  • 12.14 Mindray Bio medical Electronics Co. Ltd.
  • Exhibit 152: Mindray Bio medical Electronics Co. Ltd. - Overview
  • Exhibit 153: Mindray Bio medical Electronics Co. Ltd. - Product / Service
  • Exhibit 154: Mindray Bio medical Electronics Co. Ltd. - Key offerings
  • 12.15 Siemens AG
  • Exhibit 155: Siemens AG - Overview
  • Exhibit 156: Siemens AG - Business segments
  • Exhibit 157: Siemens AG - Key news
  • Exhibit 158: Siemens AG - Key offerings
  • Exhibit 159: Siemens AG - Segment focus
  • 12.16 Sysmex Corp.
  • Exhibit 160: Sysmex Corp. - Overview
  • Exhibit 161: Sysmex Corp. - Business segments
  • Exhibit 162: Sysmex Corp. - Key offerings
  • Exhibit 163: Sysmex Corp. - Segment focus
  • 12.17 Transasia Bio Medicals Ltd.
  • Exhibit 164: Transasia Bio Medicals Ltd. - Overview
  • Exhibit 165: Transasia Bio Medicals Ltd. - Product / Service
  • Exhibit 166: Transasia Bio Medicals Ltd. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 167: Inclusions checklist
  • Exhibit 168: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 169: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 170: Research methodology
  • Exhibit 171: Validation techniques employed for market sizing
  • Exhibit 172: Information sources
  • 13.5 List of abbreviations
  • Exhibit 173: List of abbreviations